nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2C8—Paclitaxel—ovarian cancer	0.0788	0.219	CbGbCtD
Almotriptan—CYP2D6—Vinorelbine—ovarian cancer	0.0716	0.199	CbGbCtD
Almotriptan—CYP3A4—Topotecan—ovarian cancer	0.0646	0.179	CbGbCtD
Almotriptan—CYP3A4—Vinorelbine—ovarian cancer	0.0455	0.126	CbGbCtD
Almotriptan—CYP3A4—Paclitaxel—ovarian cancer	0.032	0.0888	CbGbCtD
Almotriptan—CYP2D6—Doxorubicin—ovarian cancer	0.0271	0.0753	CbGbCtD
Almotriptan—CYP3A4—Docetaxel—ovarian cancer	0.0231	0.0642	CbGbCtD
Almotriptan—CYP3A4—Doxorubicin—ovarian cancer	0.0172	0.0479	CbGbCtD
Almotriptan—Melatonin—CYP1B1—ovarian cancer	0.00466	0.414	CrCbGaD
Almotriptan—Melatonin—ESR1—ovarian cancer	0.00314	0.28	CrCbGaD
Almotriptan—Sumatriptan—ABCB1—ovarian cancer	0.0019	0.169	CrCbGaD
Almotriptan—Eletriptan—ABCB1—ovarian cancer	0.00154	0.137	CrCbGaD
Almotriptan—Palpitations—Paclitaxel—ovarian cancer	0.000944	0.00152	CcSEcCtD
Almotriptan—Vomiting—Melphalan—ovarian cancer	0.000943	0.00152	CcSEcCtD
Almotriptan—Immune system disorder—Docetaxel—ovarian cancer	0.000939	0.00151	CcSEcCtD
Almotriptan—Loss of consciousness—Paclitaxel—ovarian cancer	0.000939	0.00151	CcSEcCtD
Almotriptan—Pain in extremity—Doxorubicin—ovarian cancer	0.000938	0.00151	CcSEcCtD
Almotriptan—Diplopia—Doxorubicin—ovarian cancer	0.000938	0.00151	CcSEcCtD
Almotriptan—Rash—Melphalan—ovarian cancer	0.000935	0.0015	CcSEcCtD
Almotriptan—Dermatitis—Melphalan—ovarian cancer	0.000934	0.0015	CcSEcCtD
Almotriptan—Chills—Docetaxel—ovarian cancer	0.000933	0.0015	CcSEcCtD
Almotriptan—Asthenia—Vinorelbine—ovarian cancer	0.00093	0.00149	CcSEcCtD
Almotriptan—Abdominal pain upper—Epirubicin—ovarian cancer	0.000926	0.00149	CcSEcCtD
Almotriptan—Convulsion—Paclitaxel—ovarian cancer	0.000925	0.00149	CcSEcCtD
Almotriptan—Hypertension—Paclitaxel—ovarian cancer	0.000922	0.00148	CcSEcCtD
Almotriptan—Pruritus—Vinorelbine—ovarian cancer	0.000917	0.00147	CcSEcCtD
Almotriptan—Breast disorder—Epirubicin—ovarian cancer	0.000916	0.00147	CcSEcCtD
Almotriptan—Mental disorder—Docetaxel—ovarian cancer	0.000911	0.00146	CcSEcCtD
Almotriptan—Chest pain—Paclitaxel—ovarian cancer	0.000909	0.00146	CcSEcCtD
Almotriptan—Myalgia—Paclitaxel—ovarian cancer	0.000909	0.00146	CcSEcCtD
Almotriptan—Arthralgia—Paclitaxel—ovarian cancer	0.000909	0.00146	CcSEcCtD
Almotriptan—Anxiety—Paclitaxel—ovarian cancer	0.000906	0.00146	CcSEcCtD
Almotriptan—Erythema—Docetaxel—ovarian cancer	0.000905	0.00145	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000903	0.00145	CcSEcCtD
Almotriptan—Nausea—Topotecan—ovarian cancer	0.0009	0.00145	CcSEcCtD
Almotriptan—Discomfort—Paclitaxel—ovarian cancer	0.000898	0.00144	CcSEcCtD
Almotriptan—Gastritis—Epirubicin—ovarian cancer	0.000897	0.00144	CcSEcCtD
Almotriptan—Muscular weakness—Epirubicin—ovarian cancer	0.000894	0.00144	CcSEcCtD
Almotriptan—Dry mouth—Paclitaxel—ovarian cancer	0.000889	0.00143	CcSEcCtD
Almotriptan—Diarrhoea—Vinorelbine—ovarian cancer	0.000887	0.00142	CcSEcCtD
Almotriptan—Dysgeusia—Docetaxel—ovarian cancer	0.000886	0.00142	CcSEcCtD
Almotriptan—Nausea—Melphalan—ovarian cancer	0.000881	0.00142	CcSEcCtD
Almotriptan—Confusional state—Paclitaxel—ovarian cancer	0.000879	0.00141	CcSEcCtD
Almotriptan—Back pain—Docetaxel—ovarian cancer	0.000876	0.00141	CcSEcCtD
Almotriptan—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000872	0.0014	CcSEcCtD
Almotriptan—Shock—Paclitaxel—ovarian cancer	0.000858	0.00138	CcSEcCtD
Almotriptan—Dizziness—Vinorelbine—ovarian cancer	0.000857	0.00138	CcSEcCtD
Almotriptan—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000857	0.00138	CcSEcCtD
Almotriptan—Nervous system disorder—Paclitaxel—ovarian cancer	0.000855	0.00137	CcSEcCtD
Almotriptan—Angina pectoris—Epirubicin—ovarian cancer	0.000854	0.00137	CcSEcCtD
Almotriptan—Tachycardia—Paclitaxel—ovarian cancer	0.000851	0.00137	CcSEcCtD
Almotriptan—Breast disorder—Doxorubicin—ovarian cancer	0.000848	0.00136	CcSEcCtD
Almotriptan—Skin disorder—Paclitaxel—ovarian cancer	0.000847	0.00136	CcSEcCtD
Almotriptan—Bronchitis—Epirubicin—ovarian cancer	0.000843	0.00135	CcSEcCtD
Almotriptan—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000843	0.00135	CcSEcCtD
Almotriptan—Gastritis—Doxorubicin—ovarian cancer	0.00083	0.00133	CcSEcCtD
Almotriptan—Muscular weakness—Doxorubicin—ovarian cancer	0.000827	0.00133	CcSEcCtD
Almotriptan—Vomiting—Vinorelbine—ovarian cancer	0.000824	0.00132	CcSEcCtD
Almotriptan—Rash—Vinorelbine—ovarian cancer	0.000817	0.00131	CcSEcCtD
Almotriptan—Dermatitis—Vinorelbine—ovarian cancer	0.000816	0.00131	CcSEcCtD
Almotriptan—Headache—Vinorelbine—ovarian cancer	0.000812	0.0013	CcSEcCtD
Almotriptan—Syncope—Docetaxel—ovarian cancer	0.000812	0.0013	CcSEcCtD
Almotriptan—Palpitations—Docetaxel—ovarian cancer	0.0008	0.00129	CcSEcCtD
Almotriptan—Photosensitivity reaction—Epirubicin—ovarian cancer	0.0008	0.00129	CcSEcCtD
Almotriptan—Loss of consciousness—Docetaxel—ovarian cancer	0.000796	0.00128	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000794	0.00128	CcSEcCtD
Almotriptan—Hyperglycaemia—Epirubicin—ovarian cancer	0.00079	0.00127	CcSEcCtD
Almotriptan—Angina pectoris—Doxorubicin—ovarian cancer	0.00079	0.00127	CcSEcCtD
Almotriptan—Insomnia—Paclitaxel—ovarian cancer	0.000788	0.00127	CcSEcCtD
Almotriptan—Convulsion—Docetaxel—ovarian cancer	0.000784	0.00126	CcSEcCtD
Almotriptan—Paraesthesia—Paclitaxel—ovarian cancer	0.000783	0.00126	CcSEcCtD
Almotriptan—Hypertension—Docetaxel—ovarian cancer	0.000782	0.00126	CcSEcCtD
Almotriptan—Bronchitis—Doxorubicin—ovarian cancer	0.00078	0.00125	CcSEcCtD
Almotriptan—Dyspnoea—Paclitaxel—ovarian cancer	0.000777	0.00125	CcSEcCtD
Almotriptan—Somnolence—Paclitaxel—ovarian cancer	0.000775	0.00124	CcSEcCtD
Almotriptan—Myalgia—Docetaxel—ovarian cancer	0.000771	0.00124	CcSEcCtD
Almotriptan—Chest pain—Docetaxel—ovarian cancer	0.000771	0.00124	CcSEcCtD
Almotriptan—Arthralgia—Docetaxel—ovarian cancer	0.000771	0.00124	CcSEcCtD
Almotriptan—Nausea—Vinorelbine—ovarian cancer	0.00077	0.00124	CcSEcCtD
Almotriptan—Dyspepsia—Paclitaxel—ovarian cancer	0.000767	0.00123	CcSEcCtD
Almotriptan—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000766	0.00123	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000765	0.00123	CcSEcCtD
Almotriptan—Conjunctivitis—Epirubicin—ovarian cancer	0.000759	0.00122	CcSEcCtD
Almotriptan—Dry mouth—Docetaxel—ovarian cancer	0.000754	0.00121	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000752	0.00121	CcSEcCtD
Almotriptan—Fatigue—Paclitaxel—ovarian cancer	0.000751	0.00121	CcSEcCtD
Almotriptan—Pain—Paclitaxel—ovarian cancer	0.000745	0.0012	CcSEcCtD
Almotriptan—Confusional state—Docetaxel—ovarian cancer	0.000745	0.0012	CcSEcCtD
Almotriptan—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00074	0.00119	CcSEcCtD
Almotriptan—Anaphylactic shock—Docetaxel—ovarian cancer	0.000739	0.00119	CcSEcCtD
Almotriptan—Epistaxis—Epirubicin—ovarian cancer	0.000737	0.00118	CcSEcCtD
Almotriptan—Sinusitis—Epirubicin—ovarian cancer	0.000733	0.00118	CcSEcCtD
Almotriptan—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000731	0.00118	CcSEcCtD
Almotriptan—Shock—Docetaxel—ovarian cancer	0.000727	0.00117	CcSEcCtD
Almotriptan—Nervous system disorder—Docetaxel—ovarian cancer	0.000724	0.00116	CcSEcCtD
Almotriptan—Tachycardia—Docetaxel—ovarian cancer	0.000721	0.00116	CcSEcCtD
Almotriptan—Feeling abnormal—Paclitaxel—ovarian cancer	0.000718	0.00115	CcSEcCtD
Almotriptan—Skin disorder—Docetaxel—ovarian cancer	0.000718	0.00115	CcSEcCtD
Almotriptan—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000713	0.00115	CcSEcCtD
Almotriptan—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000709	0.00114	CcSEcCtD
Almotriptan—Rhinitis—Epirubicin—ovarian cancer	0.000703	0.00113	CcSEcCtD
Almotriptan—Conjunctivitis—Doxorubicin—ovarian cancer	0.000703	0.00113	CcSEcCtD
Almotriptan—Hypoaesthesia—Epirubicin—ovarian cancer	0.000698	0.00112	CcSEcCtD
Almotriptan—Pharyngitis—Epirubicin—ovarian cancer	0.000696	0.00112	CcSEcCtD
Almotriptan—Abdominal pain—Paclitaxel—ovarian cancer	0.000689	0.00111	CcSEcCtD
Almotriptan—Body temperature increased—Paclitaxel—ovarian cancer	0.000689	0.00111	CcSEcCtD
Almotriptan—Epistaxis—Doxorubicin—ovarian cancer	0.000682	0.0011	CcSEcCtD
Almotriptan—Sinusitis—Doxorubicin—ovarian cancer	0.000678	0.00109	CcSEcCtD
Almotriptan—Visual impairment—Epirubicin—ovarian cancer	0.000676	0.00109	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000673	0.00108	CcSEcCtD
Almotriptan—Insomnia—Docetaxel—ovarian cancer	0.000668	0.00107	CcSEcCtD
Almotriptan—Paraesthesia—Docetaxel—ovarian cancer	0.000663	0.00107	CcSEcCtD
Almotriptan—Dyspnoea—Docetaxel—ovarian cancer	0.000659	0.00106	CcSEcCtD
Almotriptan—Somnolence—Docetaxel—ovarian cancer	0.000657	0.00106	CcSEcCtD
Almotriptan—Eye disorder—Epirubicin—ovarian cancer	0.000655	0.00105	CcSEcCtD
Almotriptan—Tinnitus—Epirubicin—ovarian cancer	0.000654	0.00105	CcSEcCtD
Almotriptan—Cardiac disorder—Epirubicin—ovarian cancer	0.000651	0.00105	CcSEcCtD
Almotriptan—Rhinitis—Doxorubicin—ovarian cancer	0.000651	0.00105	CcSEcCtD
Almotriptan—Dyspepsia—Docetaxel—ovarian cancer	0.00065	0.00104	CcSEcCtD
Almotriptan—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000646	0.00104	CcSEcCtD
Almotriptan—Pharyngitis—Doxorubicin—ovarian cancer	0.000644	0.00103	CcSEcCtD
Almotriptan—Hypersensitivity—Paclitaxel—ovarian cancer	0.000642	0.00103	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000638	0.00102	CcSEcCtD
Almotriptan—Fatigue—Docetaxel—ovarian cancer	0.000637	0.00102	CcSEcCtD
Almotriptan—Immune system disorder—Epirubicin—ovarian cancer	0.000634	0.00102	CcSEcCtD
Almotriptan—Pain—Docetaxel—ovarian cancer	0.000632	0.00102	CcSEcCtD
Almotriptan—Chills—Epirubicin—ovarian cancer	0.000629	0.00101	CcSEcCtD
Almotriptan—Visual impairment—Doxorubicin—ovarian cancer	0.000625	0.001	CcSEcCtD
Almotriptan—Asthenia—Paclitaxel—ovarian cancer	0.000625	0.001	CcSEcCtD
Almotriptan—Pruritus—Paclitaxel—ovarian cancer	0.000617	0.000991	CcSEcCtD
Almotriptan—Mental disorder—Epirubicin—ovarian cancer	0.000614	0.000987	CcSEcCtD
Almotriptan—Erythema—Epirubicin—ovarian cancer	0.000611	0.000981	CcSEcCtD
Almotriptan—Feeling abnormal—Docetaxel—ovarian cancer	0.000609	0.000978	CcSEcCtD
Almotriptan—Eye disorder—Doxorubicin—ovarian cancer	0.000606	0.000974	CcSEcCtD
Almotriptan—Tinnitus—Doxorubicin—ovarian cancer	0.000605	0.000972	CcSEcCtD
Almotriptan—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000604	0.000971	CcSEcCtD
Almotriptan—Cardiac disorder—Doxorubicin—ovarian cancer	0.000602	0.000968	CcSEcCtD
Almotriptan—Tension—Epirubicin—ovarian cancer	0.000599	0.000963	CcSEcCtD
Almotriptan—Dysgeusia—Epirubicin—ovarian cancer	0.000598	0.000961	CcSEcCtD
Almotriptan—Diarrhoea—Paclitaxel—ovarian cancer	0.000596	0.000958	CcSEcCtD
Almotriptan—Nervousness—Epirubicin—ovarian cancer	0.000593	0.000953	CcSEcCtD
Almotriptan—Back pain—Epirubicin—ovarian cancer	0.000591	0.000949	CcSEcCtD
Almotriptan—Immune system disorder—Doxorubicin—ovarian cancer	0.000586	0.000942	CcSEcCtD
Almotriptan—Abdominal pain—Docetaxel—ovarian cancer	0.000584	0.000938	CcSEcCtD
Almotriptan—Body temperature increased—Docetaxel—ovarian cancer	0.000584	0.000938	CcSEcCtD
Almotriptan—Chills—Doxorubicin—ovarian cancer	0.000582	0.000936	CcSEcCtD
Almotriptan—Dizziness—Paclitaxel—ovarian cancer	0.000576	0.000926	CcSEcCtD
Almotriptan—Vision blurred—Epirubicin—ovarian cancer	0.000575	0.000925	CcSEcCtD
Almotriptan—Mental disorder—Doxorubicin—ovarian cancer	0.000569	0.000914	CcSEcCtD
Almotriptan—Ill-defined disorder—Epirubicin—ovarian cancer	0.000567	0.00091	CcSEcCtD
Almotriptan—Erythema—Doxorubicin—ovarian cancer	0.000565	0.000908	CcSEcCtD
Almotriptan—Agitation—Epirubicin—ovarian cancer	0.000561	0.000901	CcSEcCtD
Almotriptan—Tension—Doxorubicin—ovarian cancer	0.000554	0.000891	CcSEcCtD
Almotriptan—Vomiting—Paclitaxel—ovarian cancer	0.000554	0.00089	CcSEcCtD
Almotriptan—Dysgeusia—Doxorubicin—ovarian cancer	0.000553	0.000889	CcSEcCtD
Almotriptan—Malaise—Epirubicin—ovarian cancer	0.000551	0.000885	CcSEcCtD
Almotriptan—Rash—Paclitaxel—ovarian cancer	0.00055	0.000883	CcSEcCtD
Almotriptan—Dermatitis—Paclitaxel—ovarian cancer	0.000549	0.000882	CcSEcCtD
Almotriptan—Nervousness—Doxorubicin—ovarian cancer	0.000549	0.000882	CcSEcCtD
Almotriptan—Vertigo—Epirubicin—ovarian cancer	0.000549	0.000881	CcSEcCtD
Almotriptan—Syncope—Epirubicin—ovarian cancer	0.000548	0.00088	CcSEcCtD
Almotriptan—Back pain—Doxorubicin—ovarian cancer	0.000546	0.000878	CcSEcCtD
Almotriptan—Headache—Paclitaxel—ovarian cancer	0.000546	0.000877	CcSEcCtD
Almotriptan—Hypersensitivity—Docetaxel—ovarian cancer	0.000544	0.000875	CcSEcCtD
Almotriptan—Palpitations—Epirubicin—ovarian cancer	0.00054	0.000867	CcSEcCtD
Almotriptan—Loss of consciousness—Epirubicin—ovarian cancer	0.000537	0.000862	CcSEcCtD
Almotriptan—Vision blurred—Doxorubicin—ovarian cancer	0.000532	0.000855	CcSEcCtD
Almotriptan—Asthenia—Docetaxel—ovarian cancer	0.00053	0.000852	CcSEcCtD
Almotriptan—Convulsion—Epirubicin—ovarian cancer	0.000529	0.00085	CcSEcCtD
Almotriptan—Hypertension—Epirubicin—ovarian cancer	0.000527	0.000847	CcSEcCtD
Almotriptan—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000524	0.000842	CcSEcCtD
Almotriptan—Pruritus—Docetaxel—ovarian cancer	0.000523	0.00084	CcSEcCtD
Almotriptan—Myalgia—Epirubicin—ovarian cancer	0.00052	0.000835	CcSEcCtD
Almotriptan—Chest pain—Epirubicin—ovarian cancer	0.00052	0.000835	CcSEcCtD
Almotriptan—Arthralgia—Epirubicin—ovarian cancer	0.00052	0.000835	CcSEcCtD
Almotriptan—Agitation—Doxorubicin—ovarian cancer	0.000519	0.000834	CcSEcCtD
Almotriptan—Anxiety—Epirubicin—ovarian cancer	0.000518	0.000832	CcSEcCtD
Almotriptan—Nausea—Paclitaxel—ovarian cancer	0.000518	0.000832	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000516	0.000829	CcSEcCtD
Almotriptan—Discomfort—Epirubicin—ovarian cancer	0.000514	0.000825	CcSEcCtD
Almotriptan—Malaise—Doxorubicin—ovarian cancer	0.000509	0.000819	CcSEcCtD
Almotriptan—Dry mouth—Epirubicin—ovarian cancer	0.000508	0.000817	CcSEcCtD
Almotriptan—Vertigo—Doxorubicin—ovarian cancer	0.000508	0.000816	CcSEcCtD
Almotriptan—Syncope—Doxorubicin—ovarian cancer	0.000507	0.000814	CcSEcCtD
Almotriptan—Diarrhoea—Docetaxel—ovarian cancer	0.000505	0.000812	CcSEcCtD
Almotriptan—Confusional state—Epirubicin—ovarian cancer	0.000502	0.000807	CcSEcCtD
Almotriptan—Palpitations—Doxorubicin—ovarian cancer	0.000499	0.000802	CcSEcCtD
Almotriptan—Anaphylactic shock—Epirubicin—ovarian cancer	0.000498	0.000801	CcSEcCtD
Almotriptan—Loss of consciousness—Doxorubicin—ovarian cancer	0.000497	0.000798	CcSEcCtD
Almotriptan—Shock—Epirubicin—ovarian cancer	0.00049	0.000788	CcSEcCtD
Almotriptan—Convulsion—Doxorubicin—ovarian cancer	0.000489	0.000786	CcSEcCtD
Almotriptan—Nervous system disorder—Epirubicin—ovarian cancer	0.000489	0.000785	CcSEcCtD
Almotriptan—Dizziness—Docetaxel—ovarian cancer	0.000489	0.000785	CcSEcCtD
Almotriptan—Hypertension—Doxorubicin—ovarian cancer	0.000488	0.000784	CcSEcCtD
Almotriptan—Tachycardia—Epirubicin—ovarian cancer	0.000486	0.000781	CcSEcCtD
Almotriptan—Skin disorder—Epirubicin—ovarian cancer	0.000484	0.000778	CcSEcCtD
Almotriptan—Hyperhidrosis—Epirubicin—ovarian cancer	0.000482	0.000774	CcSEcCtD
Almotriptan—Arthralgia—Doxorubicin—ovarian cancer	0.000481	0.000773	CcSEcCtD
Almotriptan—Myalgia—Doxorubicin—ovarian cancer	0.000481	0.000773	CcSEcCtD
Almotriptan—Chest pain—Doxorubicin—ovarian cancer	0.000481	0.000773	CcSEcCtD
Almotriptan—Anxiety—Doxorubicin—ovarian cancer	0.000479	0.00077	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000478	0.000767	CcSEcCtD
Almotriptan—Discomfort—Doxorubicin—ovarian cancer	0.000475	0.000764	CcSEcCtD
Almotriptan—Dry mouth—Doxorubicin—ovarian cancer	0.00047	0.000756	CcSEcCtD
Almotriptan—Vomiting—Docetaxel—ovarian cancer	0.00047	0.000755	CcSEcCtD
Almotriptan—Rash—Docetaxel—ovarian cancer	0.000466	0.000748	CcSEcCtD
Almotriptan—Dermatitis—Docetaxel—ovarian cancer	0.000465	0.000748	CcSEcCtD
Almotriptan—Confusional state—Doxorubicin—ovarian cancer	0.000465	0.000747	CcSEcCtD
Almotriptan—Headache—Docetaxel—ovarian cancer	0.000463	0.000744	CcSEcCtD
Almotriptan—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000461	0.000741	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000454	0.000729	CcSEcCtD
Almotriptan—Shock—Doxorubicin—ovarian cancer	0.000454	0.000729	CcSEcCtD
Almotriptan—Nervous system disorder—Doxorubicin—ovarian cancer	0.000452	0.000726	CcSEcCtD
Almotriptan—Insomnia—Epirubicin—ovarian cancer	0.000451	0.000724	CcSEcCtD
Almotriptan—Tachycardia—Doxorubicin—ovarian cancer	0.00045	0.000723	CcSEcCtD
Almotriptan—Skin disorder—Doxorubicin—ovarian cancer	0.000448	0.00072	CcSEcCtD
Almotriptan—Paraesthesia—Epirubicin—ovarian cancer	0.000447	0.000719	CcSEcCtD
Almotriptan—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000446	0.000716	CcSEcCtD
Almotriptan—Dyspnoea—Epirubicin—ovarian cancer	0.000444	0.000714	CcSEcCtD
Almotriptan—Somnolence—Epirubicin—ovarian cancer	0.000443	0.000712	CcSEcCtD
Almotriptan—Nausea—Docetaxel—ovarian cancer	0.000439	0.000705	CcSEcCtD
Almotriptan—Dyspepsia—Epirubicin—ovarian cancer	0.000439	0.000705	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00043	0.000691	CcSEcCtD
Almotriptan—Fatigue—Epirubicin—ovarian cancer	0.00043	0.00069	CcSEcCtD
Almotriptan—Pain—Epirubicin—ovarian cancer	0.000426	0.000685	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00042	0.000675	CcSEcCtD
Almotriptan—Insomnia—Doxorubicin—ovarian cancer	0.000417	0.00067	CcSEcCtD
Almotriptan—Paraesthesia—Doxorubicin—ovarian cancer	0.000414	0.000665	CcSEcCtD
Almotriptan—Dyspnoea—Doxorubicin—ovarian cancer	0.000411	0.00066	CcSEcCtD
Almotriptan—Feeling abnormal—Epirubicin—ovarian cancer	0.000411	0.00066	CcSEcCtD
Almotriptan—Somnolence—Doxorubicin—ovarian cancer	0.00041	0.000659	CcSEcCtD
Almotriptan—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000407	0.000655	CcSEcCtD
Almotriptan—Dyspepsia—Doxorubicin—ovarian cancer	0.000406	0.000652	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000398	0.00064	CcSEcCtD
Almotriptan—Fatigue—Doxorubicin—ovarian cancer	0.000398	0.000639	CcSEcCtD
Almotriptan—Pain—Doxorubicin—ovarian cancer	0.000394	0.000633	CcSEcCtD
Almotriptan—Abdominal pain—Epirubicin—ovarian cancer	0.000394	0.000633	CcSEcCtD
Almotriptan—Body temperature increased—Epirubicin—ovarian cancer	0.000394	0.000633	CcSEcCtD
Almotriptan—Feeling abnormal—Doxorubicin—ovarian cancer	0.00038	0.00061	CcSEcCtD
Almotriptan—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000377	0.000606	CcSEcCtD
Almotriptan—Hypersensitivity—Epirubicin—ovarian cancer	0.000367	0.00059	CcSEcCtD
Almotriptan—Body temperature increased—Doxorubicin—ovarian cancer	0.000364	0.000586	CcSEcCtD
Almotriptan—Abdominal pain—Doxorubicin—ovarian cancer	0.000364	0.000586	CcSEcCtD
Almotriptan—Asthenia—Epirubicin—ovarian cancer	0.000358	0.000574	CcSEcCtD
Almotriptan—Pruritus—Epirubicin—ovarian cancer	0.000353	0.000566	CcSEcCtD
Almotriptan—Diarrhoea—Epirubicin—ovarian cancer	0.000341	0.000548	CcSEcCtD
Almotriptan—Hypersensitivity—Doxorubicin—ovarian cancer	0.00034	0.000546	CcSEcCtD
Almotriptan—Asthenia—Doxorubicin—ovarian cancer	0.000331	0.000532	CcSEcCtD
Almotriptan—Dizziness—Epirubicin—ovarian cancer	0.00033	0.000529	CcSEcCtD
Almotriptan—Pruritus—Doxorubicin—ovarian cancer	0.000326	0.000524	CcSEcCtD
Almotriptan—Vomiting—Epirubicin—ovarian cancer	0.000317	0.000509	CcSEcCtD
Almotriptan—Diarrhoea—Doxorubicin—ovarian cancer	0.000315	0.000507	CcSEcCtD
Almotriptan—Rash—Epirubicin—ovarian cancer	0.000314	0.000505	CcSEcCtD
Almotriptan—Dermatitis—Epirubicin—ovarian cancer	0.000314	0.000504	CcSEcCtD
Almotriptan—Headache—Epirubicin—ovarian cancer	0.000312	0.000502	CcSEcCtD
Almotriptan—Dizziness—Doxorubicin—ovarian cancer	0.000305	0.00049	CcSEcCtD
Almotriptan—Nausea—Epirubicin—ovarian cancer	0.000296	0.000476	CcSEcCtD
Almotriptan—Vomiting—Doxorubicin—ovarian cancer	0.000293	0.000471	CcSEcCtD
Almotriptan—Rash—Doxorubicin—ovarian cancer	0.000291	0.000467	CcSEcCtD
Almotriptan—Dermatitis—Doxorubicin—ovarian cancer	0.00029	0.000467	CcSEcCtD
Almotriptan—Headache—Doxorubicin—ovarian cancer	0.000289	0.000464	CcSEcCtD
Almotriptan—Nausea—Doxorubicin—ovarian cancer	0.000274	0.00044	CcSEcCtD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.35e-06	0.000821	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PIK3CG—ovarian cancer	5.31e-06	0.000814	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—SLC2A1—ovarian cancer	5.25e-06	0.000806	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PARP1—ovarian cancer	5.24e-06	0.000805	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PIK3CG—ovarian cancer	5.2e-06	0.000797	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PARP1—ovarian cancer	5.14e-06	0.000788	CbGpPWpGaD
Almotriptan—MAOA—Neuronal System—HRAS—ovarian cancer	5.13e-06	0.000787	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NME2—ovarian cancer	5.11e-06	0.000784	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYTB—ovarian cancer	5.03e-06	0.000772	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP1B1—ovarian cancer	5.03e-06	0.000772	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6ST—ovarian cancer	5.02e-06	0.00077	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6ST—ovarian cancer	4.91e-06	0.000754	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CG—ovarian cancer	4.82e-06	0.00074	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PIK3CB—ovarian cancer	4.79e-06	0.000735	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—BRIP1—ovarian cancer	4.78e-06	0.000734	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPP1CC—ovarian cancer	4.78e-06	0.000734	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CG—ovarian cancer	4.72e-06	0.000724	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PIK3CD—ovarian cancer	4.67e-06	0.000716	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.58e-06	0.000702	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PIK3CD—ovarian cancer	4.57e-06	0.000701	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PPP2R1A—ovarian cancer	4.46e-06	0.000685	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPP1CC—ovarian cancer	4.4e-06	0.000675	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—BRIP1—ovarian cancer	4.4e-06	0.000675	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYTB—ovarian cancer	4.27e-06	0.000654	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PPP2R1A—ovarian cancer	4.25e-06	0.000653	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CD—ovarian cancer	4.24e-06	0.00065	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.17e-06	0.00064	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PPP2R1A—ovarian cancer	4.17e-06	0.000639	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—YAP1—ovarian cancer	4.16e-06	0.000638	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CD—ovarian cancer	4.15e-06	0.000637	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ABCB1—ovarian cancer	4.15e-06	0.000636	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PTEN—ovarian cancer	4.14e-06	0.000635	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—TYMS—ovarian cancer	4.07e-06	0.000625	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PIK3CB—ovarian cancer	4.07e-06	0.000624	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PIK3CB—ovarian cancer	3.98e-06	0.000611	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CXCL8—ovarian cancer	3.91e-06	0.0006	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.91e-06	0.000599	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CXCL8—ovarian cancer	3.83e-06	0.000587	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—IL2—ovarian cancer	3.74e-06	0.000573	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPP1CC—ovarian cancer	3.73e-06	0.000572	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—BRIP1—ovarian cancer	3.73e-06	0.000572	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CB—ovarian cancer	3.69e-06	0.000567	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—IL2—ovarian cancer	3.66e-06	0.000561	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CB—ovarian cancer	3.62e-06	0.000555	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—YAP1—ovarian cancer	3.6e-06	0.000552	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.56e-06	0.000546	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CXCL8—ovarian cancer	3.55e-06	0.000545	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.49e-06	0.000535	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CXCL8—ovarian cancer	3.48e-06	0.000533	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL2—ovarian cancer	3.39e-06	0.00052	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—FASN—ovarian cancer	3.39e-06	0.00052	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TERT—ovarian cancer	3.38e-06	0.000519	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—SLC5A5—ovarian cancer	3.34e-06	0.000512	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL2—ovarian cancer	3.32e-06	0.00051	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TERT—ovarian cancer	3.31e-06	0.000508	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYTB—ovarian cancer	3.29e-06	0.000505	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CAV1—ovarian cancer	3.28e-06	0.000503	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—SLC2A1—ovarian cancer	3.22e-06	0.000494	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—YAP1—ovarian cancer	3.21e-06	0.000492	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.18e-06	0.000487	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.13e-06	0.00048	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CAV1—ovarian cancer	3.13e-06	0.00048	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP1B1—ovarian cancer	3.09e-06	0.000474	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CAV1—ovarian cancer	3.06e-06	0.00047	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ESR1—ovarian cancer	3.01e-06	0.000462	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CG—ovarian cancer	2.99e-06	0.000458	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6ST—ovarian cancer	2.96e-06	0.000455	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—YAP1—ovarian cancer	2.95e-06	0.000453	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ESR1—ovarian cancer	2.95e-06	0.000453	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—FASN—ovarian cancer	2.93e-06	0.00045	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PIK3CA—ovarian cancer	2.92e-06	0.000448	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6ST—ovarian cancer	2.9e-06	0.000445	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—SLC5A5—ovarian cancer	2.88e-06	0.000442	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.88e-06	0.000441	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.88e-06	0.000441	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—APC—ovarian cancer	2.85e-06	0.000437	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CG—ovarian cancer	2.85e-06	0.000437	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—NRAS—ovarian cancer	2.85e-06	0.000437	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.79e-06	0.000428	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—APC—ovarian cancer	2.79e-06	0.000428	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CG—ovarian cancer	2.79e-06	0.000428	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—NRAS—ovarian cancer	2.79e-06	0.000428	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—SLC2A1—ovarian cancer	2.78e-06	0.000427	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	2.74e-06	0.00042	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—MAPK3—ovarian cancer	2.73e-06	0.000418	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.73e-06	0.000418	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.72e-06	0.000417	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—MAPK3—ovarian cancer	2.67e-06	0.00041	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP1B1—ovarian cancer	2.67e-06	0.00041	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CD—ovarian cancer	2.63e-06	0.000403	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—FASN—ovarian cancer	2.62e-06	0.000401	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—MAPK1—ovarian cancer	2.59e-06	0.000398	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—EGFR—ovarian cancer	2.59e-06	0.000398	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SLC5A5—ovarian cancer	2.57e-06	0.000395	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ABCB1—ovarian cancer	2.54e-06	0.00039	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—MAPK1—ovarian cancer	2.54e-06	0.00039	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—EGFR—ovarian cancer	2.54e-06	0.00039	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CD—ovarian cancer	2.5e-06	0.000384	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—YAP1—ovarian cancer	2.5e-06	0.000384	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—TYMS—ovarian cancer	2.5e-06	0.000383	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SLC2A1—ovarian cancer	2.49e-06	0.000381	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PIK3CA—ovarian cancer	2.48e-06	0.00038	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.47e-06	0.00038	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CD—ovarian cancer	2.45e-06	0.000376	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—KRAS—ovarian cancer	2.45e-06	0.000376	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.43e-06	0.000373	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PIK3CA—ovarian cancer	2.43e-06	0.000372	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—FASN—ovarian cancer	2.41e-06	0.000369	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—KRAS—ovarian cancer	2.4e-06	0.000368	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—AKT1—ovarian cancer	2.39e-06	0.000366	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP1B1—ovarian cancer	2.38e-06	0.000366	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	2.37e-06	0.000363	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SLC5A5—ovarian cancer	2.37e-06	0.000363	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.36e-06	0.000361	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CB—ovarian cancer	2.29e-06	0.000351	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SLC2A1—ovarian cancer	2.29e-06	0.000351	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CA—ovarian cancer	2.25e-06	0.000345	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ERBB2—ovarian cancer	2.21e-06	0.000339	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CA—ovarian cancer	2.2e-06	0.000338	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ABCB1—ovarian cancer	2.2e-06	0.000337	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP1B1—ovarian cancer	2.19e-06	0.000336	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MTOR—ovarian cancer	2.18e-06	0.000335	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CB—ovarian cancer	2.18e-06	0.000335	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.18e-06	0.000334	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ERBB2—ovarian cancer	2.16e-06	0.000332	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—TYMS—ovarian cancer	2.16e-06	0.000331	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CB—ovarian cancer	2.14e-06	0.000328	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MTOR—ovarian cancer	2.14e-06	0.000328	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	2.11e-06	0.000324	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.1e-06	0.000323	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CXCL8—ovarian cancer	2.1e-06	0.000322	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HRAS—ovarian cancer	2.08e-06	0.00032	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CXCL8—ovarian cancer	2.05e-06	0.000315	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1B—ovarian cancer	2.05e-06	0.000314	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HRAS—ovarian cancer	2.04e-06	0.000313	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—FASN—ovarian cancer	2.04e-06	0.000313	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—AKT1—ovarian cancer	2.03e-06	0.000311	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CAV1—ovarian cancer	2.01e-06	0.000309	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CASP3—ovarian cancer	2.01e-06	0.000308	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC5A5—ovarian cancer	2.01e-06	0.000308	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1B—ovarian cancer	2.01e-06	0.000308	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL2—ovarian cancer	2e-06	0.000307	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—ovarian cancer	1.99e-06	0.000306	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—AKT1—ovarian cancer	1.98e-06	0.000304	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTEN—ovarian cancer	1.98e-06	0.000304	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CASP3—ovarian cancer	1.97e-06	0.000301	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ABCB1—ovarian cancer	1.96e-06	0.000301	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL2—ovarian cancer	1.96e-06	0.000301	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCND1—ovarian cancer	1.95e-06	0.0003	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—ovarian cancer	1.95e-06	0.0003	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	1.94e-06	0.000298	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC2A1—ovarian cancer	1.94e-06	0.000297	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CTNNB1—ovarian cancer	1.93e-06	0.000297	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—YAP1—ovarian cancer	1.93e-06	0.000296	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TYMS—ovarian cancer	1.93e-06	0.000296	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCND1—ovarian cancer	1.91e-06	0.000293	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MMP9—ovarian cancer	1.9e-06	0.000291	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.9e-06	0.000291	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CTNNB1—ovarian cancer	1.89e-06	0.000291	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PTEN—ovarian cancer	1.89e-06	0.000289	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MMP9—ovarian cancer	1.86e-06	0.000285	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP1B1—ovarian cancer	1.86e-06	0.000285	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PTEN—ovarian cancer	1.85e-06	0.000283	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—AKT1—ovarian cancer	1.84e-06	0.000282	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CG—ovarian cancer	1.83e-06	0.000281	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ABCB1—ovarian cancer	1.8e-06	0.000277	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—AKT1—ovarian cancer	1.8e-06	0.000276	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TYMS—ovarian cancer	1.77e-06	0.000272	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CAV1—ovarian cancer	1.74e-06	0.000267	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—ovarian cancer	1.7e-06	0.000261	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STAT3—ovarian cancer	1.69e-06	0.000259	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NRAS—ovarian cancer	1.68e-06	0.000258	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—ovarian cancer	1.67e-06	0.000256	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.66e-06	0.000255	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STAT3—ovarian cancer	1.65e-06	0.000253	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NRAS—ovarian cancer	1.65e-06	0.000253	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	1.65e-06	0.000253	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.64e-06	0.000251	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CD—ovarian cancer	1.61e-06	0.000247	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK3—ovarian cancer	1.61e-06	0.000247	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CG—ovarian cancer	1.58e-06	0.000243	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK3—ovarian cancer	1.58e-06	0.000242	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—FASN—ovarian cancer	1.57e-06	0.000241	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MYC—ovarian cancer	1.57e-06	0.00024	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CAV1—ovarian cancer	1.55e-06	0.000238	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.55e-06	0.000237	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MYC—ovarian cancer	1.53e-06	0.000235	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK1—ovarian cancer	1.53e-06	0.000235	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EGFR—ovarian cancer	1.53e-06	0.000235	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ABCB1—ovarian cancer	1.53e-06	0.000235	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TYMS—ovarian cancer	1.5e-06	0.00023	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK1—ovarian cancer	1.5e-06	0.00023	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EGFR—ovarian cancer	1.5e-06	0.00023	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.49e-06	0.000229	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.48e-06	0.000228	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KRAS—ovarian cancer	1.45e-06	0.000222	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.43e-06	0.00022	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CAV1—ovarian cancer	1.43e-06	0.000219	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KRAS—ovarian cancer	1.42e-06	0.000217	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CG—ovarian cancer	1.41e-06	0.000217	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CB—ovarian cancer	1.4e-06	0.000216	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CA—ovarian cancer	1.4e-06	0.000214	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CD—ovarian cancer	1.39e-06	0.000214	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CA—ovarian cancer	1.33e-06	0.000204	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CA—ovarian cancer	1.3e-06	0.0002	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CG—ovarian cancer	1.3e-06	0.0002	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—ovarian cancer	1.29e-06	0.000197	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.27e-06	0.000195	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—ovarian cancer	1.26e-06	0.000193	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.24e-06	0.000191	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HRAS—ovarian cancer	1.23e-06	0.000189	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CB—ovarian cancer	1.21e-06	0.000186	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTEN—ovarian cancer	1.21e-06	0.000186	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CAV1—ovarian cancer	1.21e-06	0.000186	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HRAS—ovarian cancer	1.2e-06	0.000185	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.18e-06	0.000181	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—ovarian cancer	1.18e-06	0.000181	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TYMS—ovarian cancer	1.16e-06	0.000178	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.16e-06	0.000177	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—ovarian cancer	1.15e-06	0.000177	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CD—ovarian cancer	1.14e-06	0.000175	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKT1—ovarian cancer	1.14e-06	0.000175	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.1e-06	0.000169	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKT1—ovarian cancer	1.09e-06	0.000167	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.08e-06	0.000166	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKT1—ovarian cancer	1.06e-06	0.000163	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTEN—ovarian cancer	1.05e-06	0.000161	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CB—ovarian cancer	9.97e-07	0.000153	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CD—ovarian cancer	9.69e-07	0.000149	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTEN—ovarian cancer	9.37e-07	0.000144	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CAV1—ovarian cancer	9.34e-07	0.000143	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTEN—ovarian cancer	8.61e-07	0.000132	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CA—ovarian cancer	8.56e-07	0.000131	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CG—ovarian cancer	8.51e-07	0.00013	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CB—ovarian cancer	8.44e-07	0.00013	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CD—ovarian cancer	7.48e-07	0.000115	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CA—ovarian cancer	7.4e-07	0.000114	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTEN—ovarian cancer	7.3e-07	0.000112	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKT1—ovarian cancer	7e-07	0.000107	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CA—ovarian cancer	6.61e-07	0.000101	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CB—ovarian cancer	6.52e-07	0.0001	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CA—ovarian cancer	6.08e-07	9.32e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKT1—ovarian cancer	6.05e-07	9.28e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTEN—ovarian cancer	5.63e-07	8.64e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKT1—ovarian cancer	5.4e-07	8.28e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CA—ovarian cancer	5.15e-07	7.9e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKT1—ovarian cancer	4.96e-07	7.62e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKT1—ovarian cancer	4.21e-07	6.45e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CA—ovarian cancer	3.97e-07	6.1e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKT1—ovarian cancer	3.25e-07	4.98e-05	CbGpPWpGaD
